This is a supplement (this "Supplement") to the proxy statement dated March 24, 2023 (the "Proxy Statement") for the 2023 Annual Meeting of Stockholders (the "Annual Meeting") of Centene Corporation (the "Company") to be held at 10:00 AM, Central Time, on Wednesday, May 10, 2023, in the Centene Auditorium at Centene Plaza, 7700 Forsyth Boulevard, St. Louis, Missouri 63105.
Except as specifically amended or supplemented by the information contained in this Supplement, all information in the Proxy Statement remains unchanged and should be considered in voting your shares.
APPOINTMENT OF NEW CHAIRMAN OF THE BOARD
Effective March 31, 2023, the Board of Directors of the Company (the "Board") appointed Frederick H. Eppinger as Chairman of the Board, succeeding H. James Dallas.
COMMITTEE APPOINTMENTS
Effective March 31, 2023, in anticipation of the retirement of Orlando Ayala, Richard A. Gephardt and William L. Trubeck from the Board, Wayne DeVeydt has been appointed as the Chairman of the Audit and Compliance Committee, and the Committee membership has been revised as set forth below.
Audit and Compliance
Compensation and
Governance
Value Creation
Current Directors
Committee
Talent Committee
Committee
Committee
Orlando Ayala
Jessica L. Blume
Kenneth A. Burdick
Christopher J. Coughlin
H. James Dallas
Wayne S. DeVeydt
Frederick H. Eppinger
Monte E. Ford
Richard A. Gephardt
Sarah M. London
Lori J. Robinson
Theodore R. Samuels
William L. Trubeck
Chair Member
VOTING MATTERS
If you have already voted by internet, telephone or by mail, no action is required from you unless you wish to change your vote. The Supplement does not change the proposals to be acted on at the Annual Meeting, which are described in the Proxy Statement.
Important information regarding how to vote your shares and revoke proxies already cast is available in the Proxy Statement under the caption "Information About the Meeting."
OTHER MATTERS
The Company knows of no other matters to be submitted at the Annual Meeting. If any other matters properly come before the Annual Meeting, it is the intention of the persons named in the proxy card to vote the shares they represent as the Board may recommend. Discretionary authority with respect to such other matters is granted by the execution of the proxy, whether through telephonic or internet voting or, alternatively, by using a paper copy of the proxy card that has been requested.
We appreciate your continued support of the Company.
CENTENE CORPORATION
By: /s/ Christopher A. Koster
Christopher A. Koster
Executive Vice President, Secretary and General Counsel
Attachments
Original Link
Original Document
Permalink
Disclaimer
Centene Corporation published this content on 03 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2023 21:56:09 UTC.
Centene Corporation specializes in health services. Revenues break down by activity as follows:
- development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons;
- specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
CENTENE CORPORATION 
